dramat
farreach
advanc
understand
immunolog
benefit
human
milk
made
use
newer
techniqu
demonstr
specif
contribut
numer
bioactiv
factor
contain
human
milk
tabl
multifunct
capabl
individu
factor
interact
coordin
function
factor
longitudin
chang
rel
concentr
durat
lactat
make
human
milk
uniqu
immunolog
activ
compon
breast
milk
make
import
aspect
host
defens
mammari
gland
mother
time
complement
supplement
stimul
ongo
develop
infant
immun
system
explos
research
immunolog
properti
action
breast
milk
last
year
make
imposs
summar
import
aspect
know
immunolog
benefit
breast
milk
recent
develop
technolog
genom
studi
use
microarray
proteom
promis
continu
rapid
expans
knowledg
biolog
mammari
gland
human
milk
infant
develop
immun
system
chapter
emphas
import
concept
immunolog
benefit
refer
interest
reader
recent
literatur
extens
inform
mani
specif
compon
immunolog
benefit
human
milk
analyz
varieti
perspect
review
publish
inform
protect
infant
specif
infect
compar
breastf
formulaf
infant
develop
immun
system
action
bioactiv
factor
provid
breast
milk
examin
propos
function
activ
compon
contain
human
milk
antimicrobi
antiinflammatori
immunomodul
consid
natur
differ
factor
solubl
cellular
hormonelik
examin
contribut
breast
milk
immun
function
mammari
gland
infant
evolutionari
process
determin
site
postul
action
specif
factor
eg
breast
infant
mucos
level
respiratori
tract
gastrointestin
gi
tract
system
level
classifi
factor
rel
contribut
constitut
defens
innat
immun
versu
induc
defens
adapt
immun
infant
immun
system
clarifi
mechan
action
propos
immunolog
benefit
mucosalassoci
lymphoid
tissu
format
chapter
bioactiv
factor
level
mucosa
subsequ
action
breast
infant
consid
contribut
human
milk
develop
infant
immun
system
rel
potenti
longterm
immunolog
benefit
protect
allergi
asthma
autoimmun
diseas
inflammatori
bowel
diseas
protect
effect
breast
milk
infect
document
earli
medic
literatur
data
prove
milk
variou
speci
includ
human
protect
offspr
contain
antibodi
vast
number
antigen
veterinarian
long
known
urgenc
offspr
receiv
earli
milk
mother
death
rate
among
human
newborn
suckl
breast
third
world
least
five
time
higher
among
receiv
colostrum
mother
milk
evid
lack
breastfeed
poor
environment
sanit
pernici
synergist
effect
infant
mortal
rate
present
habicht
studi
women
malaysia
evid
breastfeed
protect
infect
digest
respiratori
tract
report
sever
decad
howev
mani
older
studi
critic
flaw
methodolog
perform
develop
countri
risk
infect
due
poor
sanit
expect
higher
variou
research
propos
specif
criteria
assess
methodolog
studi
report
protect
effect
breast
milk
clearli
identifi
measur
outcom
definit
breastfeed
method
limit
bia
control
confound
variabl
recent
studi
incorpor
mani
propos
methodolog
criteria
continu
document
breastfeed
protect
infant
diarrhea
respiratori
infect
otiti
media
individu
paper
report
protect
urinari
tract
infect
neonat
sepsi
sever
paper
document
decreas
risk
die
infanc
associ
refer
exclus
predomin
breastfeed
pakistan
peru
ghana
india
nepal
bangladesh
systemat
review
bellagio
child
surviv
studi
group
predict
exclus
breastfeed
infant
month
age
could
prevent
childhood
death
occur
younger
year
age
recent
review
human
breast
milk
document
evid
protect
infecti
diseas
breastfeed
resourcerich
resourcepoor
countri
one
import
consider
rel
measur
immunolog
benefit
breast
milk
exclus
durat
breastfeed
basic
concept
identifi
doserespons
relationship
amount
breast
milk
receiv
infant
period
observ
immunolog
benefit
gain
greater
exclus
durat
equal
greater
volum
breast
milk
dose
dr
labbok
krasovec
care
defin
breastfeed
term
pattern
breastfeed
rel
amount
supplement
formula
fluid
food
fullnearli
full
medium
equal
low
partial
token
standard
use
equat
term
differ
studi
box
outlin
definit
amount
breastfeed
raisler
et
al
refer
doserespons
relationship
studi
effect
dose
breast
milk
prevent
ill
infant
full
breastfeed
associ
lowest
rate
ill
diarrhea
cough
wheez
even
children
equal
breastfeed
evid
lower
odd
ratio
ear
infect
certain
ill
number
longterm
studi
demonstr
greater
protect
infect
increas
exclus
breastfeed
durat
least
month
coupl
paper
demonstr
dose
effect
rel
decreas
occurr
late
onset
sepsi
lowbirthweight
infant
prematur
infant
associ
infant
receiv
least
mlkg
per
day
mother
milk
compar
receiv
nutrit
current
recommend
american
academi
pediatr
reinforc
import
doserespons
relationship
breastfeed
benefit
breastfeed
recommend
exclus
breastfeed
first
month
life
least
partial
breastfeed
introduct
solid
food
addit
month
longer
anoth
import
consider
rel
exclus
breastfeed
potenti
effect
food
fluid
infant
diet
could
neg
influenc
immunolog
benefit
infectionprotect
effect
level
gi
mucosa
human
immun
system
begin
form
develop
fetu
newborn
infant
immun
system
immatur
inadequ
birth
immun
system
rapidli
adapt
postnat
period
relat
natur
matur
skin
mucos
barrier
respons
exposur
infant
inhal
ingest
antigen
microbi
agent
extrauterin
environ
infant
immun
system
develop
throughout
least
first
year
life
overal
infant
limit
abil
respond
effect
quickli
infecti
challeng
explain
infant
ongo
suscept
infect
box
list
better
understood
defici
infant
immun
system
extens
discuss
development
immun
defici
affect
infant
present
lawrenc
pane
blymphocyt
immunoglobulin
product
defici
amount
specif
antibodi
produc
limit
isotyp
switch
slow
matur
antibodi
respons
specif
antigen
polysaccharid
system
cellmedi
immun
respons
includ
complement
compon
classic
altern
pathway
limit
complement
activ
numer
immun
compon
produc
limit
amount
infanc
includ
complement
secretori
immunoglobulin
ig
interleukin
tumor
necrosi
factor
tnf
lactoferrin
lysozym
rel
variou
immun
deficit
infant
one
find
variou
bioactiv
immunomodul
factor
breast
milk
potenti
capabl
complement
enhanc
develop
infant
mucos
system
immun
system
concept
bioactiv
immunomodul
factor
breast
milk
import
area
evolv
research
extens
review
literatur
intens
focu
research
center
effect
human
milk
infant
gi
tract
bioactiv
factor
studi
divers
protein
lactoferrin
lysozym
etc
hormon
erythropoietin
prolactin
insulin
etc
growth
factor
epitheli
growth
factor
insulinlik
growth
factor
etc
neuropeptid
neurotensin
somatostatin
etc
cytokin
etc
antiinflammatori
agent
enzym
antioxid
etc
nucleotid
see
tabl
past
adequ
point
list
factor
especi
immunoglobulin
explain
immunolog
benefit
breast
milk
today
necessari
understand
multifunct
dynam
action
individu
factor
specif
mechan
action
innat
adapt
mucos
immun
system
role
direct
infect
protect
normal
develop
infant
immun
system
contribut
potenti
harm
inflamm
evolutionari
perspect
matern
antibodi
transmit
fetu
differ
pathway
differ
speci
associ
recogn
number
placent
membran
rel
import
placenta
colostrum
sourc
antibodi
analysi
hors
six
placent
membran
pass
littl
antibodi
transplacent
reli
total
colostrum
protect
foal
human
monkey
three
placent
membran
receiv
antibodi
via
placenta
less
colostrum
transfer
igg
human
accomplish
activ
transport
mechan
immunoglobulin
across
placenta
secretori
iga
siga
immunoglobulin
found
human
milk
provid
local
protect
mucou
membran
gi
tract
investig
establish
mammari
gland
secret
milk
import
protect
infant
colostrum
also
matur
milk
birth
earli
month
life
although
predomin
iga
human
colostrum
milk
long
describ
import
phenomenon
fulli
appreci
discoveri
iga
predomin
immunoglobulin
present
mucos
secret
gland
addit
breast
mucos
immun
becom
subject
extens
research
clear
consider
traffic
cell
occur
mucos
epithelia
secretori
lymphoid
tissu
site
data
support
concept
gener
system
mucosaassoci
lymphoid
tissu
malt
includ
gut
lung
mammari
gland
salivari
lacrim
gland
genit
tract
figur
immun
respons
malt
reaction
immunogen
mucos
site
may
effect
mean
produc
immun
distant
site
antibodi
specif
antigen
found
milk
also
found
saliva
evid
transfer
protect
two
differ
distant
site
simultan
evid
suggest
mammari
gland
may
act
extens
gutassoci
lymphoid
tissu
galt
possibl
bronchioleassoci
lymphoid
tissu
abil
epitheli
surfac
expos
extern
environ
defend
infecti
agent
well
document
gi
genitourinari
respiratori
tract
siga
secretori
igm
sigm
produc
adapt
respons
mucosallymphoid
immun
system
act
block
colon
pathogen
limit
passag
harm
antigen
across
mucos
barrier
activ
b
cell
cytokin
pass
mammari
gland
contribut
product
siga
breast
milk
direct
contact
antigen
lymphoid
cell
breast
unlik
peyer
patch
tonsil
malt
structur
appear
well
develop
birth
nevertheless
actual
effect
product
siga
variou
antigen
present
infant
mucos
surfac
respiratori
gi
tract
still
inadequ
protect
infect
breastfeed
infant
part
maternalinf
dyad
expos
antigen
via
mucos
servic
receiv
protect
siga
sigm
mother
breast
milk
produc
mother
malt
figur
protect
properti
human
milk
divid
cellular
factor
humor
factor
facil
discuss
although
close
relat
vivo
wide
varieti
solubl
cellular
compon
hormonelik
agent
identifi
human
milk
colostrum
see
tabl
although
follow
discuss
separ
element
import
emphas
constitu
human
milk
multifunct
function
vivo
interact
probabl
coordin
complementari
cell
import
postpartum
compon
matern
immunolog
endow
year
ago
cell
bodi
describ
colostrum
anim
much
lactat
research
studi
colostr
corpuscl
undertaken
dairi
industri
commerci
reason
earli
research
afford
opportun
make
major
progress
understand
cell
milk
initi
thought
cell
repres
reaction
infect
mammari
gland
even
describ
pu
cell
becom
clear
cell
milk
normal
constitu
colostrum
speci
cell
includ
macrophag
lymphocyt
neutrophil
epitheli
cell
total
approxim
cell
fragment
epitheli
cell
examin
electron
microscop
fresh
sampl
women
brooker
found
membranebound
cytoplasm
fragment
sediment
pellet
outnumb
intact
cell
fragment
mostli
secretori
cell
contain
numer
cisterna
rough
endoplasm
reticulum
lipid
droplet
golgi
vesicl
contain
casein
micel
secretori
epitheli
cell
found
sampl
second
month
postpartum
began
outnumb
macrophag
ductal
epitheli
cell
popul
cell
first
week
disappear
sampl
contain
squamou
epitheli
cell
origin
galactophor
skin
nippl
live
leukocyt
normal
present
human
milk
overal
concentr
leukocyt
order
magnitud
seen
peripher
blood
although
predomin
cell
milk
macrophag
rather
neutrophil
macrophag
compos
leukocyt
present
lymphocyt
make
cell
much
lower
concentr
human
blood
number
cell
found
human
milk
increas
mastiti
larg
small
lymphocyt
present
indirect
immunofluoresc
antitcel
antibodi
identifi
thymusderiv
lymphocyt
shown
human
colostr
lymphocyt
cell
human
milk
lymphocyt
cell
immunofluoresc
procedur
detect
surfac
immunoglobulin
characterist
b
lymphocyt
identifi
b
lymphocyt
number
leukocyt
degre
mitogen
stimul
lymphocyt
sharpli
declin
first
month
lactat
essenti
undetect
level
accord
ogra
ogra
figur
enumer
total
cell
number
milk
difficult
variou
techniqu
compar
coulter
electron
particl
counter
visual
cell
count
special
stain
filter
trap
fluoresc
detect
autom
fluoresc
cell
count
stain
deoxyribonucl
acid
dna
superior
techniqu
macrophag
largecomplex
phagocyt
contain
lysosom
mitochondria
pinosom
ribosom
golgi
apparatu
monocyt
phagocyt
lipid
laden
previous
call
colostr
bodi
donn
function
morpholog
featur
phagocyt
human
tissu
sourc
featur
includ
ameboid
movement
phagocytosi
microorgan
fungi
bacteria
kill
bacteria
product
complement
compon
lysosom
lactoferrin
milk
macrophag
activ
includ
follow
phagocytosi
latex
adher
glass
secret
lysozym
complement
compon
erythrocyt
adher
iggmedi
erythrocyt
adher
phagocytosi
bacteri
kill
inhibit
lymphocyt
mitogen
respons
releas
intracellular
iga
tissu
cultur
giant
cell
format
interact
lymphocyt
data
suggest
macrophag
also
amplifi
tcell
reactiv
direct
cellular
cooper
antigen
process
colostr
macrophag
suggest
potenti
vehicl
storag
transport
immunoglobin
signific
increas
iga
igg
synthesi
colostr
lymphocyt
incub
supernat
cultur
macrophag
report
macrophag
may
also
particip
biosynthesi
excret
lactoperoxidas
cellular
growth
factor
enhanc
growth
intestin
epithelium
matur
intestin
brushbord
enzym
mobil
macrophag
inhibit
lymphokin
migrat
inhibitor
factor
produc
antigenstimul
sensit
lymphocyt
activ
macrophag
demonstr
fresh
colostrum
colostr
cell
cultur
certain
function
alter
compar
counterpart
human
peripher
blood
highest
concentr
cell
occur
first
day
lactat
reach
million
per
millilit
milk
colostrum
day
postpartum
contain
leukocytesml
polymorphonuclear
cell
pmn
matur
milk
ie
day
fewer
cell
see
figur
approxim
ml
pmn
week
pmn
present
function
pmn
normal
includ
microbi
kill
phagocytosi
chemotact
respons
stimul
hexos
monophosph
shunt
activ
stimul
nitroblu
tetrazolium
dye
reduct
stimul
oxygen
consumpt
milk
pmn
compar
serum
activ
often
less
serum
pmn
cell
whether
milk
pmn
actual
perform
role
protect
infant
studi
mani
investig
use
mani
techniqu
briefli
anim
studi
shown
mammari
gland
suscept
infect
earli
lactat
dramat
increas
pmn
occur
mammari
inflamm
presenc
peripher
neutropenia
chronic
mastiti
sever
infect
gland
occur
impli
accord
buescher
picker
primari
function
milk
pmn
defend
mammari
tissu
per
se
impart
immunocompet
newborn
may
explain
presenc
larg
number
pmn
rel
hypofunct
earli
disappear
time
evid
show
neutrophil
found
human
milk
demonstr
sign
activ
includ
increas
express
adher
glycoprotein
decreas
express
lselectin
spontan
product
granulocytemacrophag
colonystimul
factor
gmcsf
abil
transform
dendrit
cell
dc
human
milk
macrophag
morpholog
motil
activ
cell
movement
cell
threedimension
system
greater
monocyt
counterpart
peripher
blood
activ
neutrophil
may
play
role
phagocytosi
level
mucosa
gi
tract
supplement
infant
poor
abil
recruit
phagocyt
site
b
lymphocyt
present
human
milk
colostrum
part
immunolog
system
human
milk
cell
lymphocyt
breast
milk
human
milk
lymphocyt
respond
mitogen
prolifer
increas
macrophagelymphocyt
interact
releas
solubl
mediat
includ
migrat
inhibitor
factor
cell
destin
becom
lymphopoiet
cell
deriv
two
separ
influenc
thymu
bursa
b
bursal
equival
tissu
popul
b
cell
make
smaller
part
total
synthes
iga
antibodi
term
b
cell
deriv
origin
differ
anatom
site
thymu
bird
identifi
bursa
fabriciu
b
cell
identifi
presenc
surfac
immunoglobulin
marker
b
cell
human
milk
includ
cell
iga
igm
igg
surfac
immunoglobulin
b
cell
transform
plasma
cell
remain
sessil
tissu
mammari
gland
rapid
mitot
activ
occur
thymu
gland
lymphat
organ
yet
cell
die
within
cell
substanc
thymu
locat
much
tcell
differenti
select
play
major
role
develop
infant
immun
system
thymosin
identifi
hormon
produc
thymic
epitheli
cell
expand
peripher
lymphocyt
popul
emerg
thymu
gland
cell
acquir
new
surfac
antigen
marker
cell
circul
lymphat
vascular
system
longliv
lymphocyt
call
recircul
pool
popul
restrict
region
lymph
node
form
thymicdepend
area
interest
note
exclus
breastf
infant
significantli
larger
thymu
formulaf
infant
month
signific
lymphocyt
human
milk
afford
immunolog
benefit
breastf
infant
continu
investig
suggest
lymphocyt
sensit
induc
immunolog
toler
incit
graftversushost
reaction
accord
head
beer
lymphocyt
may
incorpor
suckl
tissu
achiev
shortterm
adopt
immun
neonat
studi
activ
lymphocyt
carri
number
investig
collect
sampl
milk
lactat
women
variou
time
postpartum
examin
number
cell
type
present
studi
activ
cell
vitro
ogra
ogra
collect
sampl
women
measur
cell
content
day
see
figur
compar
respons
lymphocyt
colostrum
milk
cell
peripher
blood
tcell
subpopul
also
shown
surfac
epitop
similar
peripher
blood
greatest
number
cell
appear
first
day
count
rang
total
cell
fifth
day
count
drop
first
day
count
addit
number
erythrocyt
rosetteform
cell
determin
use
sheep
erythrocyteroset
techniqu
erythrocyt
rosett
format
lymphocyt
constitut
mean
first
day
fifth
day
day
total
cell
lymphocyt
erythrocyt
rosett
format
lymphocyt
investig
compar
valu
peripher
blood
mother
level
remain
essenti
constant
similar
studi
bhaskaram
reddi
sampl
milk
time
women
found
compar
cell
concentr
examin
bactericid
activ
milk
leukocyt
found
compar
circul
leukocyt
blood
irrespect
stage
lactat
state
nutrit
mother
ogra
ogra
also
studi
lymphocyt
prolifer
respons
colostrum
milk
antigen
data
show
respons
stimul
viral
antigen
rubella
cmv
mump
analysi
cellmedi
immun
microbi
antigen
show
milk
lymphocyt
limit
potenti
recogn
respond
certain
infecti
agent
compar
cell
peripher
circul
thought
intercellular
action
caus
lack
extern
factor
contrast
cell
b
cell
shown
uniqu
reactiv
seen
peripher
blood
colostr
lymphocyt
deriv
matur
rather
immatur
tcell
subset
distribut
tcell
subset
colostrum
includ
cell
distribut
cell
colostrum
human
milk
lower
serum
fewer
cell
exist
cell
percentag
cell
higher
serum
either
postpartum
donor
normal
control
subject
correl
exist
length
gestat
number
cell
normal
blood
usual
contain
twice
mani
lymphocyt
parm
et
al
partial
purifi
propag
milk
lymphocyt
vitro
studi
immunolog
function
milk
lymphocyt
respond
uniqu
manner
stimuli
known
activ
lymphocyt
serum
author
found
milk
lymphocyt
hyporespons
nonspecif
mitogen
histocompat
antigen
allogen
cell
laboratori
found
unrespons
candida
albican
signific
prolifer
lymphocyt
occur
respons
k
capsular
antigen
escherichia
coli
lymphocyt
blood
fail
respond
antigen
support
concept
local
mammari
tissu
immun
tlymphocyt
level
recent
experi
rodent
provid
evid
lymphocyt
reactiv
transplant
alloantigen
adopt
immun
suckl
newborn
foster
nurs
experi
perform
rodent
shown
newborn
rat
expos
allogen
milk
manifest
alter
reactiv
skin
allograft
foster
mother
strain
anim
mother
may
give
suckl
newborn
immunoreact
lymphocyt
influenc
matern
milk
cell
develop
neonat
immunocompet
demonstr
sever
differ
immunolog
context
congenit
athym
nude
mice
nurs
phenotyp
normal
mother
normal
foster
mother
increas
surviv
mother
contribut
tcellhelp
activ
suckl
newborn
colostr
lymphocyt
prolifer
respons
variou
mitogen
alloantigen
convent
antigen
colostr
cell
surviv
neonat
stomach
gut
experiment
anim
remain
viabl
upper
gi
tract
week
evid
howev
indic
transepitheli
migrat
take
place
neonat
mice
fosternurs
newli
deliv
anim
whose
colostr
cell
tag
hthymidin
cell
human
milk
studi
use
marker
employ
cell
peripher
blood
lymphocyt
cell
equal
distribut
subpopul
tcell
receptor
princip
type
cell
common
leukocyt
cell
helper
suppressorinduc
subset
cell
leukocyt
cytotox
noncytotox
subset
cell
human
milk
presum
activ
display
increas
phenotyp
marker
activ
includ
hladr
receptor
major
cell
human
milk
consist
effector
memori
cell
cell
effect
produc
consist
phenotyp
featur
human
milk
may
supplement
infant
function
immun
cell
compens
identifi
defici
infant
pauciti
memori
cell
juto
studi
effect
human
milk
bcell
function
cellfre
defat
filter
colostrum
well
matur
breast
milk
show
enhanc
effect
bcell
prolifer
gener
antibodi
secret
seen
formula
juto
suggest
could
repres
import
immunolog
mechan
goldblum
et
al
abl
show
bcell
respons
human
colostrum
e
coli
given
mother
oral
accompani
system
respons
mother
suggest
breast
breast
milk
reflect
site
local
humor
cellmedi
immun
initi
induc
distant
site
gut
transfer
via
reactiv
lymphoid
cell
migrat
breast
head
beer
provid
scheme
describ
mechan
see
figur
diagram
depict
progeni
specif
sensit
lymphocyt
origin
galt
specif
peyer
patch
migrat
mammari
gland
infiltr
mammari
gland
secret
suppli
breast
immun
cell
capabl
select
immun
respons
ogra
ogra
suggest
cell
may
select
accumul
breast
pregnanc
respons
milk
cell
antibodi
repres
individu
total
immun
immunocompet
cell
initi
stimul
galt
recircul
extern
mucos
surfac
popul
lamina
propria
antibodyproduc
plasma
cell
substanti
number
antigensensit
cell
select
homein
stroma
mammari
gland
initi
local
iga
antibodi
synthesi
antigen
initi
encount
respiratori
intestin
mucosa
recent
work
humanmilkderiv
b
cell
demonstr
breast
milk
contain
activ
memori
b
cell
differ
blood
cell
express
mucos
adhes
molecul
suggest
origin
mammari
gland
similar
galtassoci
b
cell
mucosaeassoci
epitheli
cytokin
may
contribut
migrat
retent
cell
mammari
gland
inform
support
concept
mammari
gland
effector
site
mucos
immun
system
accumul
epidemiolog
research
support
concept
colostrum
milk
provid
human
infant
immunolog
benefit
b
lymphocyt
found
breast
milk
reactiv
organ
invad
intestin
tract
howev
proof
specif
viral
bacteri
protect
secondari
action
immunolog
activ
b
cell
demonstr
although
clear
cell
provid
colostrum
milk
effect
impact
cell
neonat
depend
abil
surviv
gi
tract
demonstr
sever
speci
includ
human
ph
stomach
low
output
hydrochlor
acid
minim
first
month
peptic
activ
immedi
feed
begin
ph
rise
return
normal
hour
cell
milk
toler
studi
rat
also
shown
intact
nucleat
lymphoid
cell
found
stomach
intestin
cell
remov
rat
stomach
capabl
phagocytosi
lymphoid
cell
milk
shown
travers
mucos
wall
human
milk
store
howev
cellular
compon
toler
heat
c
f
cool
c
f
lyophil
although
cell
may
identifi
process
milk
viabl
cregan
et
al
report
presenc
mammari
stem
cell
human
breast
milk
base
demonstr
cytokeratin
mammari
stem
cell
marker
addit
cell
breast
milk
analyz
cultur
show
multipot
stem
cell
marker
nestin
cytokeratin
marker
although
human
milk
may
serv
sourc
mammari
stem
cell
futur
evid
immunolog
role
cell
develop
infant
current
exist
class
immunoglobulin
found
human
milk
studi
immunoglobulin
enhanc
techniqu
electrophoresi
chromatograph
radioimmunoassay
compon
identifi
associ
protein
matern
serum
other
found
exclus
milk
concentr
highest
colostrum
speci
concentr
chang
lactat
proce
iga
princip
siga
highest
colostrum
although
postpartum
level
fall
throughout
next
week
substanti
level
maintain
throughout
first
year
gradual
wean
month
even
partial
breastfeed
infant
receiv
solid
food
second
year
life
figur
tabl
specif
siga
antibodi
e
coli
persist
lactat
may
even
increas
see
figur
main
immunoglobulin
human
serum
igg
iga
content
one
fifth
level
igg
milk
howev
revers
true
iga
import
immunoglobulin
milk
concentr
also
biolog
activ
siga
like
synthes
mammari
alveolar
cell
lymphocyt
migrat
peyer
patch
gi
tract
lymphoid
tissu
respiratori
tract
via
lymphat
breast
cytokin
caus
isotyp
switch
local
igm
b
cell
becom
iga
b
lymphocyt
isotyp
switch
cell
travel
breast
transform
plasma
cell
produc
secretori
dimer
iga
enteromammari
pathway
mother
provid
increas
amount
siga
infant
microorgan
present
mother
infant
environ
brandtzaeg
et
al
propos
model
transport
iga
polymer
igm
pentamer
produc
plasma
cell
across
secretori
epithelium
format
siga
igm
bind
secretori
compon
attach
epitheli
membran
occur
membran
mammari
epitheli
cell
lactat
quantit
determin
immunoglobulin
human
milk
made
milk
collect
birth
long
month
postpartum
peitersen
et
al
iga
predomin
immunoglobulin
breast
milk
constitut
immunoglobulin
colostrum
milk
ogra
ogra
studi
serum
postpartum
lactat
mother
nonpregn
match
control
subject
note
individu
mean
concentr
ig
class
lower
postpartum
subject
level
statist
signific
igg
mg
higher
nonpregn
women
immunoglobulin
level
particularli
iga
igm
high
colostrum
drop
precipit
first
day
igg
show
declin
volum
mammari
secret
howev
increas
dramat
period
thu
absolut
amount
immunoglobulin
remain
nearli
constant
would
first
appear
local
product
concentr
iga
probabl
igm
may
take
place
mammari
gland
deliveri
ige
igd
also
measur
colostrum
milk
use
radioimmunoassay
techniqu
colostrum
found
contain
concentr
iuml
ige
sampl
less
remaind
igd
found
sampl
concentr
mgdl
plasma
level
poorli
correl
find
suggest
possibl
local
mammari
product
rather
posit
transfer
question
whether
ige
igd
antibodi
breast
milk
similar
specif
antigen
iga
antibodi
milk
remain
unansw
keller
et
al
examin
question
local
mammari
igd
product
possibl
particip
mucos
immun
system
compar
colostrum
plasma
level
total
igd
specif
igd
antibodi
work
compar
colostrumplasma
ratio
igg
igd
albumin
measur
igd
specif
antigen
author
report
evid
igd
particip
respons
mucos
immun
system
increas
total
igd
igd
specif
antigen
found
colostrum
address
question
total
quantiti
immunolog
compon
secret
human
milk
per
day
avail
infant
butt
et
al
lysozym
contrast
rose
period
total
amount
avail
amount
per
kilogram
per
day
author
suggest
product
secret
immunolog
factor
mammari
gland
may
link
catabol
compon
infant
mucos
tissu
concentr
siga
igg
igm
lactoferrin
lysozym
globulin
compar
relationship
pariti
age
mother
consist
trend
observ
matur
pregnanc
consid
howev
mean
concentr
protein
higher
except
iga
deliveri
prematur
sever
protein
human
milk
physiolog
function
infant
davidson
examin
surviv
human
milk
protein
gi
tract
cross
immunoelectrophoresi
show
three
human
milk
protein
transvers
entir
intestin
present
fece
lactoferrin
siga
antitrypsin
miranda
et
al
report
effect
matern
nutrit
statu
immunolog
substanc
human
colostrum
milk
matern
malnutrit
character
lower
weighttoheight
ratio
creatineheight
index
total
serum
protein
igg
iga
malnourish
mother
colostrum
contain
one
third
normal
concentr
igg
less
half
normal
level
albumin
lower
iga
complement
lysozym
complement
igm
level
normal
level
improv
develop
matur
milk
improv
matern
nutrit
accord
one
report
moder
exercis
lactat
affect
level
iga
lactoferrin
lysozym
breast
milk
immunolog
compon
contain
human
milk
second
year
lactat
becom
signific
point
infant
nurs
longer
longitudin
studi
lactat
second
year
goldman
et
al
women
includ
fulli
breastf
infant
month
year
continu
partial
breastfe
sampl
collect
fulli
empti
breast
electr
pump
tabl
summar
concentr
measur
factor
leukocyt
detect
concentr
total
iga
siga
lactoferrin
lysozym
similar
month
postpartum
gradual
wean
siga
antibodi
e
coli
produc
second
year
demonstr
signific
immunolog
benefit
infant
continu
breastfeed
iga
igm
igg
measur
nurs
women
begin
lactat
simultan
fece
children
jatsyk
et
al
academi
medicin
moscow
report
iga
high
milk
rapidli
increas
fece
igg
igm
level
howev
low
milk
fece
normal
fullterm
bottlef
infant
iga
appear
fece
week
age
much
lower
level
breastf
infant
koutra
report
first
week
life
increas
amount
siga
found
stool
breastf
infant
compar
formulaf
infant
author
ascrib
phenomenon
presenc
siga
human
milk
stimul
local
gi
product
immunoglobulin
savilahti
et
al
measur
serum
level
igg
iga
igm
infant
month
age
month
exclus
breastf
infant
igg
igm
level
significantli
lower
wean
earli
month
formula
six
infant
still
exclus
breastf
month
iga
level
also
lower
level
found
month
bottl
feeder
infect
rate
similar
two
month
children
wean
formula
igg
igm
level
compar
iron
zinc
level
children
siga
antibodi
identifi
human
milk
recogn
larg
varieti
microorgan
siga
antibodi
recogn
bacteria
virus
parasit
fungi
list
tabl
list
virus
siga
antibodi
exist
human
milk
equal
long
includ
enterovirus
polioviru
coxsacki
echoviru
cytomegaloviru
cmv
herp
simplex
viru
human
immunodefici
viru
hiv
semliki
forest
viru
respiratori
syncyti
viru
rsv
rubella
reoviru
type
rotaviru
measl
noroviru
porcin
coronaviru
igg
igm
antibodi
also
exist
human
milk
cmv
rsv
rubella
well
ige
antibodi
parvoviru
nogueraobenza
cleari
review
role
breast
milk
siga
provid
protect
infant
variou
agent
specif
caus
bacteri
enter
preserv
human
milk
c
month
decreas
significantli
level
iga
igg
igm
lactoferrin
lysozym
preserv
siga
freez
c
c
recent
confirm
hine
et
al
varieti
differ
heat
treatment
appli
milk
protect
bacteri
contamin
protect
infect
specif
infecti
agent
especi
hiv
cmv
heat
treatment
includ
lowtemperatur
shorttim
c
minut
holder
pasteur
c
minut
hightemperatur
shorttim
c
second
boil
c
greater
minut
steril
variabl
time
period
pretoria
pasteur
c
approxim
minut
flash
heat
c
approxim
minut
peak
temperatur
c
microwav
heat
milk
temperatur
c
second
boil
steril
essenti
destroy
immunolog
activ
siga
lysozym
activ
drop
holder
pasteur
c
neither
lowtemperatur
shorttim
hightemperatur
shorttim
reduc
siga
lysozym
content
markedli
igg
igm
greatli
reduc
holder
pasteur
siga
differ
antigen
serum
iga
iga
synthes
nonlact
well
lactat
breast
compact
molecul
resist
proteolyt
enzym
intestin
tract
low
ph
stomach
siga
present
human
milk
primarili
manufactur
plasma
cell
mammari
gland
modifi
transloc
across
mammari
epithelia
minim
produc
cellular
lymphocyt
milk
level
milk
time
higher
serum
level
cow
milk
low
tenth
level
matur
human
milk
mgdl
later
life
human
intestin
tract
subepitheli
plasma
cell
secret
iga
intestin
secret
siga
occur
neonat
period
increas
month
life
discuss
continu
whether
antibodi
absorb
intestin
tract
although
probabl
absorb
almost
ingest
iga
milk
surviv
passag
intestin
tract
excret
fece
immunoglobulin
class
identifi
fece
larg
bodi
evid
demonstr
activ
immunoglobulin
especi
iga
mucos
level
gi
respiratori
tract
antibodi
provid
local
intestin
protect
microorgan
may
infect
mucosa
enter
bodi
gut
respiratori
tract
well
establish
predomin
bacteria
found
breastf
infant
bifid
bacteria
bifid
bacteria
gramposit
nonmotil
anaerob
bacilli
mani
observ
shown
strike
differ
flora
gut
breastf
bottlef
infant
demonstr
presenc
specif
factor
colostrum
milk
support
growth
lactobacillu
bifidu
bifidu
factor
character
dialyz
nitrogencontain
carbohydr
contain
amino
acid
vitro
studi
beeren
et
al
show
presenc
specif
growth
factor
bifidobacterium
bifidum
human
milk
call
bb
milk
includ
cow
milk
sheep
milk
pig
milk
infant
formula
promot
growth
speci
show
activ
support
b
infanti
b
longum
growth
factor
found
stabl
milk
frozen
heat
freezedri
store
month
growthpromot
factor
present
six
strain
studi
vari
resist
physic
chang
factor
activ
vitro
requir
presenc
intestin
enzym
activ
possibl
show
presenc
growth
factor
mammalian
milk
thu
may
contribut
implant
persist
b
bifidum
breastf
infant
intestin
lactobacillu
describ
one
number
probiot
bacteria
provid
immun
protect
benefit
host
lactobacillu
reportedli
stimul
antibodi
product
improv
phagocytosi
blood
leukocyt
use
probiot
bacteria
reportedli
produc
benefit
varieti
situat
associ
infect
addit
bacteria
formula
anoth
exampl
tri
make
formula
better
make
like
breast
milk
hatakka
et
al
examin
possibl
effect
ad
probiot
bacteria
formula
occurr
infect
children
attend
day
care
report
modest
reduct
number
children
complic
respiratori
infect
lower
respiratori
tract
infect
well
number
children
receiv
antibiot
respiratori
infect
group
children
receiv
formula
supplement
lactobacillu
rhamnosu
gg
compar
children
receiv
unsuppl
formula
well
known
preantibiot
era
human
milk
protect
human
infant
throughout
lactat
staphylococc
infect
identifi
presenc
antistaphylococc
factor
experi
young
mice
stress
staphylococci
factor
demonstr
direct
antibiot
properti
term
resist
factor
describ
nondialyz
thermost
part
free
fatti
acid
part
phosphid
fraction
probabl
distinct
linol
acid
human
milk
contain
nonspecif
antimicrobi
factor
lysozym
thermost
acidst
enzym
enzym
glycoprotein
hydrolyz
linkag
nacetylglucosamin
nacetylmuram
acid
bacteri
cell
wall
found
larg
concentr
stool
breastf
infant
stool
formulaf
infant
thu
thought
influenc
flora
intestin
tract
goldman
et
al
describ
initi
fall
lysozym
level
mgml
mgml
week
increas
month
mgml
see
lysozym
level
show
increas
time
lactat
find
appar
indian
women
western
world
reddi
et
al
studi
level
lysozym
wellnourish
poorli
nourish
women
india
found
differ
tabl
shown
studi
lysozym
level
increas
lactat
level
human
milk
time
level
cow
milk
lysozym
bacteriostat
enterobacteriacea
gramposit
bacteria
secret
neutrophil
macrophag
present
mani
bodi
secret
adult
studi
immunolog
compon
human
milk
second
year
lactat
goldman
et
al
report
concentr
lysozym
lactoferrin
total
siga
similar
uninterrupt
lactat
gradual
wean
month
siga
antibodi
e
coli
also
produc
second
year
author
state
support
idea
enteromammari
lymphocyt
traffic
pathway
lead
develop
lymphoid
cell
mammari
gland
produc
iga
antibodi
enter
organ
oper
throughout
lactat
cow
milk
formula
ad
human
milk
reduc
effect
lysozym
howev
powder
human
milk
fortifi
enfamil
inhibit
antiinfect
properti
lactoferrin
ironbind
protein
close
relat
serum
iron
transport
protein
transferrin
part
larger
transferrin
protein
famili
lactoferrin
found
mucos
secret
tear
saliva
vagin
fluid
urin
nasal
bronchial
secret
bile
gi
fluid
notabl
milk
colostrum
bacteriostat
effect
lactoferrin
well
establish
wide
rang
microorgan
includ
gramposit
gramneg
aerob
anaerob
virus
parasit
fungi
origin
propos
mechan
action
bacteriostat
effect
depriv
microorgan
iron
second
antibacteri
action
involv
direct
action
bacteri
surfac
bind
neg
charg
molecul
lipoteicho
acid
surfac
gramposit
bacteria
neutral
surfac
charg
allow
action
antibacteri
factor
like
lysozym
bind
lipid
gramneg
bacteria
releas
lipid
produc
damag
cell
membran
anoth
antibacteri
action
bind
bacteri
adhes
block
host
cell
interact
lactoferrin
kill
candida
albican
c
krusei
chang
permeabl
fungal
cell
surfac
lactoferrin
consid
multifunct
immunoregulatori
protein
biolog
role
lactoferrin
review
sever
studi
point
lactoferrin
revers
bind
two
ferric
ion
affin
iron
time
greater
transferrin
retain
iron
ph
human
lactoferrin
strongli
basic
lactoferrin
normal
unsatur
iron
usual
less
satur
iron
human
milk
oral
iron
therapi
infant
interfer
bacteriostat
action
lactoferrin
depend
unsatur
state
portion
bacteriostat
function
reddi
et
al
show
give
iron
mother
interfer
satur
lactoferrin
milk
thu
potenti
bacteriostat
effect
protein
energi
malnutrit
rather
iron
suppli
influenc
lactoferrin
synthesi
mammari
gland
malnourish
nonirondefici
mother
lactoferrin
defici
concentr
lactoferrin
high
mgdlthen
progress
declin
next
month
lactat
level
mgdl
breast
milk
also
contain
small
amount
transferrin
mgml
lactoferrin
total
protein
content
human
milk
lactoferrin
resist
proteolysi
especi
ironsatur
form
intact
lactoferrin
detect
stool
infant
higher
proport
lactoferrin
measur
stool
prematur
infant
intact
lactoferrin
fragment
detect
urin
prematur
infant
although
absorpt
less
like
fullterm
infant
absorpt
iron
breast
milk
directli
enhanc
lactoferrin
mani
bacteria
requir
iron
normal
growth
one
bacteriostat
effect
lactoferrin
ascrib
ironbind
action
neutrophil
lactoferrin
within
neutrophil
granul
tightli
bind
iron
neutrophil
excess
iron
ineffici
destroy
bacteria
lactoferrin
limit
growth
microorgan
helicobact
pylori
neisseria
treponema
shigella
speci
receptor
lactoferrin
directli
bind
iron
allow
adequ
growth
evid
support
variou
propos
mechan
action
lactoferrin
antimicrobi
effect
lactoferrin
shown
limit
format
biofilm
specif
organ
inhibit
adhes
host
cell
organ
directli
bind
viral
particl
herp
simplex
viru
hiv
adenoviru
proteolyt
action
lactoferrin
appear
inactiv
virul
factor
organ
separ
lactoferrin
bind
directli
glycosaminoglycan
gag
integrin
interrupt
bind
variou
virus
herp
simplex
viru
hiv
adenoviru
cmv
hepat
b
viru
hbv
host
cell
pepsin
hydrolys
product
lactoferrin
b
h
may
exert
direct
bactericid
effect
bind
lipopolysaccharid
gramneg
organ
disrupt
bacteri
membran
lactoferrin
may
caus
increas
releas
cytokin
cell
includ
antiinflammatori
cytokin
other
shown
lactoferrin
suppress
releas
proinflammatori
cytokin
would
immunemodul
effect
investig
use
recombin
human
lactoferrin
talactoferrin
demonstr
evid
lactoferrin
caus
increas
matur
dc
talactoferrin
caus
recruit
activ
neutrophil
macrophag
exampl
lactoferrin
affect
innat
immun
protect
grow
infant
sever
effect
propos
lactoferrin
includ
inhibit
hydroxyl
radic
format
decreas
local
cell
damag
lipopolysaccharid
bind
also
lead
diminish
inflammatori
respons
dna
bind
affect
transcript
possibl
regul
product
cell
product
activ
natur
killer
nk
cell
modul
complement
activ
block
adhes
enterotoxigen
e
coli
shigella
flexneri
propos
action
lactoferrin
specif
region
lactoferrin
near
n
terminu
molecul
strongli
basic
report
mediat
lactoferrin
antimicrobi
activ
lactoferricin
small
peptid
contain
basic
region
produc
proteolyt
cleavag
reportedli
bind
lipopolysaccharid
lead
disrupt
bacteri
cell
wall
cytoplasm
membran
anoth
area
immun
protect
lactoferrin
may
limit
cancer
develop
propos
mechan
anticanc
effect
includ
increas
nk
cell
cytotox
increas
product
inhibit
angiogenesi
augment
apoptosi
cancer
cell
initi
cell
cycl
arrest
grow
tumor
cell
multipl
role
propos
mechan
action
lactoferrin
breastf
infant
continu
specif
elucid
colostr
cell
cultur
shown
stimul
secret
interferonlik
substanc
strong
antivir
activ
nation
institut
health
unitsml
properti
yet
identifi
supernat
colostrum
milk
produc
cell
human
milk
stimul
vitro
cell
isol
human
milk
phenotyp
identifi
sourc
interferon
srivastava
et
al
measur
low
level
colostrum
also
transit
matur
milk
postul
low
level
pgml
might
adequ
protect
infect
without
hyperactiv
cell
interferon
produc
nk
cell
cell
phenotyp
caus
increas
express
major
histocompat
complex
molecul
increas
macrophag
function
inhibit
ige
product
produc
antitumor
antivir
activ
exact
role
breast
milk
delin
compon
complement
known
abil
fuse
bacteria
bound
specif
antibodi
present
colostrum
low
concentr
compar
level
serum
igg
igm
activ
complement
proactiv
describ
iga
ige
identifi
stimul
system
activ
opson
anaphylact
chemotact
properti
import
lysi
bacteria
bound
specif
antibodi
function
role
complement
breast
milk
identifi
unsatur
vitamin
b
bind
protein
high
molecular
weight
found
high
level
human
milk
meconium
stool
breastf
infant
compar
level
infant
formula
infant
formula
fed
protein
bind
render
vitamin
b
unavail
bacteri
growth
e
coli
bacteroid
glycan
complex
carbohydr
structur
attach
variou
structur
lactos
moieti
lipid
compon
peptid
protein
aminoglycan
present
larg
amount
human
milk
includ
glycoprotein
glycolipid
gangliosid
glycosaminoglycan
mucin
oligosaccharid
oligosaccharid
compos
basic
core
structur
deriv
glucos
galactos
nacetylglucosamin
link
varieti
termin
fucos
linkag
sialic
acid
linkag
creat
numer
differ
compound
oligosaccharid
compos
major
portion
glycoconjug
milk
present
milkfat
globul
membran
skim
milk
gangliosid
glycolipid
found
plasma
membran
cell
especi
cell
gray
matter
brain
specif
gangliosid
glycosphingolipid
contain
sialic
acid
hexos
hexos
amin
carbohydr
compon
ceramid
lipid
compon
molecul
predomin
gangliosid
human
milk
report
newburg
divers
abund
complex
carbohydr
synthes
mani
glycosyltransferas
contain
mammari
gland
mucin
lactadherin
two
glycoprotein
includ
group
antimicrobi
effect
carbohydr
molecul
structur
similar
glycan
surfac
small
intestin
epitheli
cell
act
receptor
microorgan
one
propos
mechan
antimicrobi
effect
solubl
substanc
direct
bind
potenti
pathogen
organ
schroten
et
al
propos
mucin
contain
human
milk
fatglobul
membran
block
bacteri
adhes
throughout
intestin
studi
adhes
sfimbriat
e
coli
buccal
epitheli
cell
gangliosid
appear
respons
block
activ
heatlabil
enterotoxin
e
coli
toxin
vibrio
cholera
rat
intestin
loop
prepar
anoth
toxin
campylobact
jejuni
similar
bind
specif
also
seem
inhibit
globotriaosylceramid
anoth
glycolipid
human
milk
natur
cell
surfac
receptor
toxin
shigella
dysenteria
verotoxin
releas
enterohemorrhag
e
coli
propos
mechan
action
glycolipid
bind
toxin
form
stabl
complex
prevent
toxin
bind
appropri
receptor
intestin
cell
howev
crane
et
al
propos
studi
oligosaccharid
bind
toxin
receptor
block
action
heatstabl
enterotoxin
e
coli
human
milk
gangliosid
may
import
protect
infant
toxininduc
diarrhea
specif
demonstr
vivo
control
trial
evid
exist
human
milk
glycan
inhibit
broad
rang
pathogen
tabl
newberg
et
al
document
constitut
express
variou
fucosyl
glycan
human
milk
secret
present
typic
concentr
activ
agent
human
milk
literatur
secret
relat
secretor
lewi
gene
control
individu
differ
express
lewi
blood
group
type
chaturvedi
et
al
recent
examin
surviv
oligosaccharid
human
milk
infant
intestin
demonstr
concentr
oligosaccharid
higher
infant
fece
mother
milk
higher
fece
urin
profil
oligosaccharid
found
infant
similar
found
mother
milk
formulaf
infant
lower
concentr
oligosaccharid
profil
oligosaccharid
differ
found
breastf
infant
oligosaccharid
remain
intact
pass
intestin
small
percentag
absorb
excret
intact
urin
oligosaccharid
avail
site
block
intestin
urinari
pathogen
two
group
research
document
variat
composit
glycan
human
milk
first
month
lactat
variat
composit
glycan
divers
popul
therefor
divers
repertoir
glycan
present
larg
amount
human
milk
persist
intact
intestin
reach
urin
demonstr
inhibitori
effect
varieti
pathogen
compon
constitut
major
contribut
human
milk
innat
immun
level
infant
gut
gangliosid
gm
cholera
toxin
author
propos
gangliosid
may
play
immunomodulatori
role
earli
lactat
affect
dc
decreas
product
interleukin
suppress
express
variou
cluster
design
cd
marker
major
histocompat
complex
class
ii
dc
interleukin
il
consid
subgroup
cytokin
origin
cytokin
first
hypothes
thought
primarili
produc
leukocyt
act
leukocyt
therefor
could
call
il
although
much
effect
lymphocyt
activ
differenti
known
il
act
produc
varieti
cell
goldman
et
al
identifi
breast
milk
tabl
srivastava
et
al
report
measur
moder
amount
differ
stage
breast
milk
low
amount
detect
especi
comparison
amount
receptor
antagonist
ra
presum
could
block
activ
small
amount
hawk
et
al
report
amount
cytokin
breast
milk
first
week
lactat
propos
proinflammatori
cytokin
present
mother
donat
sampl
point
throughout
studi
broad
rang
concentr
cytokin
seen
cours
studi
antiinflammatori
cytokin
transform
growth
factor
tgf
present
signific
amount
sampl
also
report
breast
milk
mother
test
milk
aqueou
level
correl
plasma
level
constitut
produc
milk
cell
sampl
product
markedli
increas
stimul
cell
con
identifi
breast
milk
investig
especi
first
day
life
author
suggest
human
milk
may
augment
newborn
immun
function
bodi
begin
full
product
cytokin
specif
accomplish
increas
antibodi
product
especi
iga
enhanc
phagocytosi
activ
cell
increas
antitrypsin
product
mononuclear
phagocyt
chemokin
known
improv
thymic
output
anim
appear
relat
prolifer
surviv
cell
stage
develop
ngom
et
al
describ
improv
thymic
function
exclus
breastf
infant
associ
higher
concentr
mother
breast
milk
breast
milk
gambian
mother
contain
variabl
level
geometr
mean
level
higher
first
week
postpartum
mother
whose
infant
born
harvestseason
januari
june
compar
mother
whose
infant
born
hungryseason
author
postul
breast
milk
enhanc
tcell
prolifer
surviv
overal
thymic
develop
infant
lead
longterm
benefit
protect
infect
chemokin
capabl
attract
activ
neutrophil
attract
cell
produc
mammari
epitheli
cell
srivastava
et
al
also
detect
messeng
ribonucl
acid
mrna
suggest
cell
breast
milk
capabl
produc
exact
function
breast
milk
remain
elucid
thought
antiinflammatori
effect
includ
decreas
product
proinflammatori
cytokin
report
enhanc
iga
igg
igm
synthesi
identifi
colostrum
earli
milk
matur
milk
highest
level
occur
colostrum
associ
preterm
deliveri
complic
pregnanc
mother
level
correl
solubl
fa
ligand
colostrum
detect
immunohistochem
stain
activ
secret
epitheli
cell
lactat
breast
shown
produc
intestin
epitheli
cell
activ
macrophag
lead
product
chemokin
gmcsf
induc
express
fa
ligand
lymphocyt
author
suggest
present
colostrum
may
play
role
stimul
system
h
respons
caus
nk
cell
macrophag
activ
neonat
interact
direct
effect
il
breast
milk
must
clarifi
amount
cell
bear
marker
recent
activ
increas
human
milk
compar
result
peripher
blood
adult
wirt
et
al
mani
bioactiv
substanc
identifi
human
milk
cytokin
recent
identifi
investig
agent
although
exist
long
suspect
attempt
explain
certain
immunolog
protect
effect
breast
milk
infant
cytokin
describ
identifi
human
milk
cytokin
small
protein
glycoprotein
bind
receptor
immun
nonimmun
cell
produc
broad
rang
effect
mani
still
unidentifi
autocrin
paracrin
endocrin
action
cytokin
produc
predominantli
immun
cell
function
complex
associ
cytokin
stimul
control
develop
normal
function
immun
system
nomenclatur
abbrevi
use
complic
confus
newer
system
classif
establish
accord
cell
produc
gener
function
base
rel
posit
cystein
residu
receptor
type
ccr
cxcr
box
provid
simplifi
list
abbrevi
littl
evid
demonstr
specif
vivo
activ
differ
cytokin
base
gener
inform
function
interact
particular
cytokin
well
consider
yet
unexplain
effect
breast
milk
propos
function
cytokin
includ
initi
develop
host
defens
stimul
host
defens
prevent
autoimmun
antiinflammatori
effect
upper
respiratori
tract
gi
tract
stimul
develop
digest
system
especi
mucos
immun
system
alimentari
tract
proxim
respiratori
tract
matern
breast
may
respond
feedback
stimul
suppress
secret
cytokin
influenc
growth
differenti
secretori
function
breast
shown
situat
cytokin
may
enhanc
receptor
express
cell
respiratori
gi
tract
major
histocompat
complex
molecul
immunoglobulin
variou
cell
type
mucos
immun
system
may
activ
attract
specif
site
gi
tract
action
cytokin
beyond
propos
benefici
effect
cytokin
newer
studi
identifi
specif
leukocyt
inhibitori
factor
lif
immunolog
protect
role
differ
cytokin
develop
infant
exampl
extens
work
done
epiderm
growth
factor
egf
growth
factor
hbegf
gcsf
epo
epolik
growth
factor
studi
rel
role
prevent
necrot
enterocol
nec
gut
homeostasi
number
potenti
role
egf
gut
homeostasi
propos
studi
includ
intestin
develop
prolifer
adapt
respons
damag
repair
regener
diminish
inflammatori
respons
variou
stimuli
studi
role
initi
stimul
iga
product
earli
infanc
actual
measur
cytokin
breast
milk
complic
number
factor
includ
differ
assay
use
bioassay
enzymelink
immunosorb
assay
elisa
radioimmunoassay
bind
protein
exist
monomer
polymer
form
presenc
antagonist
vari
presenc
colostrum
earli
milk
matur
milk
goldman
et
al
report
bioactiv
concentr
cytokin
breast
milk
work
other
see
tabl
lower
level
matur
milk
well
high
level
solubl
receptor
also
identifi
exist
free
breast
milk
associ
tnf
receptor
vivo
signific
find
remain
assess
given
complex
interact
regul
cytokin
product
cytokin
relat
coordin
inflammatori
antiinflammatori
respons
tissu
one
assum
interact
cytokin
breast
milk
effect
cytokin
cytokin
receptor
solubl
express
variou
cell
type
cytokin
antagonist
infant
equal
complex
new
methodolog
antibodybas
protein
array
appli
identifi
cytokin
human
milk
kverka
et
al
analyz
colostrum
milk
sampl
first
day
postpartum
use
two
differ
array
capabl
detect
cytokin
three
cytokin
egf
detect
test
sampl
nineteen
cytokin
present
sampl
addit
cytokin
identifi
human
milk
first
time
concentr
cytokin
vari
differ
women
vari
time
continu
investig
assay
essenti
understand
signific
specif
effect
substanc
breast
milk
nucleotid
nucleosid
nucleic
acid
relat
metabol
product
essenti
mani
biolog
process
although
essenti
nutrient
synthes
endogen
recov
vivo
salvag
sourc
presenc
diet
may
carri
signific
benefit
variou
condit
ie
condit
essenti
situat
diseas
stress
rapid
growth
limit
dietari
intak
supplement
diet
nucleotid
may
decreas
energi
expenditur
synthes
salvag
nucleotid
optim
host
respons
advers
situat
nucleotid
exist
rel
larg
amount
human
milk
nonprotein
nitrogen
suggest
nutrit
signific
although
clinic
syndrom
associ
nucleotid
defici
date
nucleotid
present
natur
milk
differ
speci
vari
amount
composit
nucleotid
content
composit
bovin
milk
particularli
less
differ
human
milk
infant
formula
supplement
nucleotid
contain
roughli
amount
nucleotid
human
milk
mgl
unsuppl
formula
contain
less
differ
amount
nucleotid
mammalian
cell
contain
larg
varieti
nucleotid
relat
product
mani
metabol
function
includ
follow
energi
metabol
adenosin
triphosph
major
form
avail
cellular
energi
nucleic
acid
precursor
monomer
unit
rna
dna
present
physiolog
mediat
cyclic
adenosin
monophosph
cyclic
guanosin
monophosph
serv
messeng
cellular
process
adenosin
diphosph
necessari
platelet
aggreg
adenosin
shown
affect
vasodilat
relat
product
function
coenzym
metabol
pathway
nicotinamideadenin
dinucleotid
flavin
adenin
dinucleotid
coenzym
ry
molecul
synthet
reaction
uridin
diphosph
glucos
glycogen
synthesi
guanosin
diphosph
mannos
guanosin
diphosphatefucos
uridin
diphosphategalactos
cytidin
monophosph
sialic
acid
glycoprotein
synthesi
alloster
effector
intracellular
concentr
nucleotid
influenc
progress
certain
step
metabol
pathway
cellular
agonist
extracellular
nucleotid
influenc
intracellular
signal
transduct
eg
cyclic
adenosin
monophosph
inositolcalcium
pathway
nucleotid
concentr
cell
tissu
maintain
de
novo
synthesi
salvag
intermediari
metabol
diet
figur
nucleosid
predomin
product
absorb
small
intestin
nucleosid
probabl
transport
passiv
diffus
carriermedi
process
purin
pyrimidin
transport
passiv
diffus
high
concentr
sodiumdepend
activ
mechan
low
concentr
figur
digest
absorpt
nucleotid
nucleosid
pyrimidin
purin
also
involv
polymer
monomer
nucleotid
adduct
nucleosid
biolog
activ
moieti
earli
report
nucleotid
nucleosid
content
milk
variou
method
measur
use
amount
describ
either
monomer
fraction
nucleotid
total
rna
leach
et
al
recogn
complex
natur
digest
absorpt
nucleotid
relat
product
attempt
measur
total
potenti
avail
nucleosid
tpan
human
milk
use
solidphas
extract
highperform
liquid
chromatographi
analysi
enzymat
hydrolysi
variou
fraction
analyz
breast
milk
sampl
variou
stage
throughout
lactat
colostrum
transit
earli
late
matur
milk
european
women
american
women
use
aqueou
tpanfortifi
solut
contain
ribonucleosid
polymer
rna
nucleosidecontain
adduct
estim
accuraci
process
mean
rang
tpan
valu
similar
european
women
differ
countri
american
women
although
broad
rang
seen
composit
individu
nucleotid
vari
mean
tpan
valu
lowest
colostrum
show
consist
upward
downward
trend
transit
earli
late
matur
milk
mean
rang
tpan
valu
mmoll
colostrum
mmoll
transit
milk
mmoll
earli
matur
milk
mmoll
late
matur
milk
tabl
monomer
polymer
nucleotid
predomin
form
tpan
pool
sampl
cytidin
guanosin
adenosin
found
mainli
fraction
wherea
uridin
found
primarili
free
nucleotid
adduct
conclud
process
estim
tpan
includ
sequenti
enzymat
hydrolys
measur
entir
nucleotid
fraction
provid
reason
estim
vivo
process
nucleotid
avail
infant
human
milk
propos
effect
dietari
nucleotid
includ
effect
immun
system
iron
absorpt
intestin
flora
plasma
lipoprotein
growth
intestin
hepat
cell
effect
immun
system
relat
nucleotid
supplement
diet
mainli
report
anim
studi
includ
increas
mortal
rate
graftversushost
diseas
improv
delayedtyp
cutan
hypersensit
alloantigeninduc
lymphoprolifer
revers
malnutrit
starvationinduc
immunosuppress
increas
resist
challeng
aureu
c
albican
enhanc
tcell
matur
function
spleen
cell
mice
fed
nucleotidefre
diet
produc
lower
level
express
lower
level
receptor
decreas
nk
cell
activ
macrophag
activ
presum
nucleotideassoci
chang
relat
thelperinduc
cell
initi
phase
antigen
process
lymphocyt
prolifer
vitro
vivo
experi
document
ingest
nucleotid
increas
iron
absorpt
perhap
affect
xanthin
oxidas
although
vitro
studi
show
ad
nucleotid
enhanc
growth
bifidobacteria
conflict
result
obtain
influenc
dietari
nucleotid
fecal
flora
infant
receiv
breast
milk
nucleotidesuppl
formula
clinic
studi
infant
receiv
nucleotidesuppl
formula
demonstr
increas
highdens
lipoprotein
cholesterol
lower
verylowdens
lipoprotein
cholesterol
increas
longchain
polyunsatur
fatti
acid
chang
red
blood
cell
membran
phospholipid
composit
supplement
studi
anim
shown
enhanc
gi
tract
growth
matur
improv
intestin
repair
diarrhea
stimul
hepat
growth
augment
recoveri
hepatectomi
recent
review
discuss
effect
dietari
nucleotid
immun
system
protect
infect
report
studi
literatur
carver
et
al
form
nucleosidephosphatephosphatex
x
biolog
relev
moieti
eg
uridin
diphosphategalactos
nicotinamideadenin
dinucleotid
month
nk
cell
activ
product
higher
breastf
nucleotidesuppl
group
compar
receiv
formula
without
nucleotid
supplement
infect
occur
infrequ
group
slightli
less
breastf
group
differ
note
hematolog
profil
plasma
chemistri
valu
toxic
intoler
associ
nucleotid
supplement
sampl
size
small
mark
variabl
seen
measur
differ
note
month
less
month
therefor
author
conclud
dietari
nucleotid
may
contribut
improv
immun
breastf
infant
brunser
et
al
examin
effect
nucleotidesuppl
formula
incid
diarrhea
infant
chile
studi
month
age
although
infant
receiv
supplement
formula
mgl
experienc
less
diarrhea
differ
durat
diarrhea
small
number
small
comment
caus
agent
diarrhea
although
appar
protect
one
agent
seen
benefici
effect
nucleotid
diarrhea
propos
secondari
enhanc
immun
respons
intestin
pathogen
improv
intestin
integr
combin
larger
studi
infant
younger
month
age
sever
diarrhea
durat
number
bowel
movement
well
incid
diarrhea
lower
nucleotid
supplement
group
two
group
prematur
infant
fed
either
nucleotid
supplement
mgl
unsuppl
formula
follow
measur
concentr
plasma
immunoglobulin
throughout
first
month
life
igg
plasma
concentr
differ
two
group
studi
period
igm
plasma
level
higher
nucleotid
supplement
group
day
month
life
iga
plasma
level
significantli
higher
month
age
supplement
group
picker
et
al
publish
control
random
studi
infant
examin
effect
ad
nucleotid
level
compar
human
milk
infant
immun
respons
variou
vaccin
antigen
nonrandom
infant
receiv
breast
milk
least
month
either
human
milk
standard
infant
formula
anoth
infant
random
receiv
either
standard
infant
formula
one
supplement
nucleotid
amount
actual
nucleotid
content
ad
base
tpan
measur
leach
et
al
equal
mgl
overal
growth
nutrit
toler
similar
group
nucleotid
group
significantli
higher
geometr
mean
titer
h
influenza
type
b
antibodi
diphtheria
antibodi
control
group
breastf
infant
signific
differ
seen
nucleotid
control
group
igg
respons
oral
polioviru
vaccin
tetanu
infant
breastf
longer
month
significantli
higher
antibodi
respons
oral
polioviru
vaccin
children
breastf
less
month
either
two
formulaf
group
signific
differ
found
differ
group
respect
total
igg
iga
ige
differ
seen
number
children
experienc
least
one
episod
diarrhea
nucleotid
group
versu
control
group
p
breastf
group
notabl
breastf
group
heterogen
rel
amount
breast
milk
receiv
durat
feed
wherea
nucleotid
group
receiv
supplement
entir
month
question
remain
concern
nucleotid
propos
benefici
effect
infant
diet
includ
follow
proven
mechan
action
propos
benefit
form
concentr
nucleotid
necessari
effect
benefit
adequ
inform
avail
justifi
use
nucleotid
infant
formula
higher
amount
differ
composit
current
use
debat
research
answer
question
concern
nucleotid
continu
primari
function
bodi
differ
mucos
surfac
immunolog
distinct
mucos
surfac
multipl
physiolog
function
includ
ga
exchang
lung
nutrient
absorpt
gut
sensori
detect
eye
nose
mouth
reproduct
uteru
vagina
thin
permeabl
natur
barrier
mucos
surfac
larg
surfac
area
constant
exposur
microorgan
foreign
protein
chemic
predispos
mucos
membran
damag
infect
first
year
life
infant
immun
system
develop
matur
system
mucos
basi
well
involv
innat
adapt
immun
mechan
develop
must
includ
abil
respond
protect
invas
pathogen
time
toler
ignor
multitud
commens
organ
resid
surfac
earli
develop
breast
milk
contain
numer
bioactiv
factor
supplement
immun
protect
mucos
level
limit
inflamm
contribut
immun
modul
growth
stimul
infant
mucos
system
immun
defens
mucos
immun
system
involv
innat
mechan
adapt
immun
mechan
function
concert
develop
mucos
immun
system
occur
prenat
period
continu
postnat
period
function
mucos
barrier
includ
action
enzym
chemic
acid
ph
mucu
immun
globulin
indigen
flora
earli
week
gestat
age
research
identifi
chang
intestin
barrier
develop
enterocyt
goblet
cell
enterochromaffin
cell
along
evid
develop
tight
junction
epitheli
cell
mucu
product
block
adher
pathogen
epitheli
cell
demonstr
preand
postnat
develop
begin
evid
express
gene
earli
week
gestat
age
approxim
time
paneth
cell
appear
intestin
crypt
cell
secret
variou
product
includ
lysozym
secretori
phospholipas
contribut
protect
pathogen
stem
cell
protect
within
epithelia
layer
influenc
select
number
commens
organ
secretori
immun
globulin
siga
igm
act
epitheli
surfac
larg
without
inflamm
limit
adher
transmigr
facilit
phagocytosi
potenti
pathogen
wellrecogn
malt
present
local
area
beneath
mucos
surfac
tonsil
adenoid
nasopharynx
peyer
patch
isol
lymphoid
follicl
intestin
overli
isol
lymphoid
follicl
gut
special
epitheli
cell
call
mcell
mcell
membran
microfold
multifenestr
cell
come
direct
contact
microorgan
antigen
due
lack
surfac
glycocalyx
cover
remark
cell
endocytos
phagocytos
transcytos
molecul
antigen
lumin
surfac
basal
surfac
antigenpres
cell
lymphocyt
process
trancytos
molecul
present
submucos
aggreg
lymphocyt
activ
lymphocyt
respond
specif
present
antigen
migrat
via
lymphat
thorac
duct
blood
lymphocyt
circul
blood
return
mucos
tissu
predominantli
one
origin
function
effector
lymphocyt
lamina
propria
process
direct
migrat
specif
site
occur
due
influenc
cytokin
adhes
molecul
chemokin
mucos
epithelia
chemokin
express
colon
salivari
gland
thymusexpress
chemokin
effect
sitespecif
migrat
immun
respons
lymphocyt
submucosa
subsequ
direct
migrat
mucos
site
produc
focus
respons
select
repertoir
antigen
site
lactat
mammari
gland
essenti
compon
malt
mother
matur
effect
immun
respons
microorgan
infant
environ
antigen
stimul
malt
mother
gut
respiratori
mucosa
direct
migrat
cell
breast
result
activ
lymphocyt
antibodi
breast
milk
provid
protect
infant
microorgan
wellrecogn
exampl
breast
milk
provid
addit
immun
protect
infant
also
one
reason
continu
breastfeed
mother
infant
possibl
infect
mucos
immun
system
undergo
signific
postnat
develop
part
due
dramat
exposur
mucosa
larg
number
microorgan
earli
postnat
life
peyer
patch
rudimentari
immunoglobulinproduc
intestin
plasma
cell
present
sever
week
birth
sever
week
germin
center
within
lymphoid
follicl
develop
number
igmand
igaproduc
cell
intestin
increas
immunoglobulinproduc
intestin
plasma
cell
primarili
igaproduc
cell
lamina
propria
increas
number
month
age
normal
matur
mucos
immun
system
larg
number
immunoglobulinproduc
cell
locat
intestin
lamina
propria
monomer
iga
produc
plasma
cell
transport
epitheli
cell
mucos
lumen
attach
epitheli
glycoprotein
membran
secretori
compon
two
iga
molecul
lead
format
dimera
siga
molecul
secret
mucos
surfac
igm
form
pentam
contain
polypeptid
jchain
transport
mechan
portion
secretori
compon
remain
attach
siga
igm
protect
molecul
proteolysi
contribut
stabil
larg
amount
siga
igm
produc
similar
fashion
mammari
gland
deliv
infant
via
breast
milk
siga
igm
remain
stabl
saliva
fece
provid
specif
protect
block
adher
entri
facilit
inactiv
neutral
agglutin
wide
varieti
microorgan
distinct
action
immunoglobulin
larg
number
bioactiv
factor
breast
milk
act
mucos
level
supplement
innat
defens
includ
lactoferrin
lysozym
casein
oligosaccharid
glycoconjug
lipid
lactadherin
glycosaminoglycan
antimicrobi
compon
part
milkfat
globul
freefatti
acid
monoglycerid
digest
compon
milkfat
globul
caus
lysi
envelop
virus
bacteria
fungi
protozoa
lauric
linol
acid
constitut
larg
percentag
ffe
human
milk
two
acid
produc
lipolysi
stomach
addit
factor
contain
breast
milk
demonstr
activ
level
mucosa
includ
cytokin
hormon
growth
factor
act
influenc
epitheli
barrier
integr
factor
consid
contribut
mucos
growth
develop
egf
hormon
insulin
insulinlik
growth
factor
mani
factor
contain
breast
milk
potenti
activ
level
mucosa
includ
nutrient
vitamin
nucleotid
enzym
solubl
molecul
receptorlik
structur
solubl
solubl
tolllik
receptor
tolllik
receptor
tlr
complex
interact
indigen
bacteri
flora
intestin
import
aspect
research
develop
mucos
immun
system
forchielli
walker
review
mani
immun
mechan
act
mucos
level
tlr
transmembran
receptor
pattern
recognit
receptor
capabl
detect
discrimin
among
variou
group
potenti
pathogen
initi
differ
immun
respons
tlr
recogn
pathogenassoci
molecular
pattern
conserv
featur
pattern
molecul
express
pathogen
commens
organ
specif
tlr
recogn
particular
repertoir
pattern
identifi
bacteri
lipoprotein
peptidoglycan
molecul
recogn
doublestrand
dna
identifi
lipopolysaccharid
ten
tlr
recogn
human
date
identifi
legend
pathogenassoci
molecular
pattern
virus
bacteria
protozoa
bind
tlr
present
epitheli
cell
predominantli
express
macrophag
dc
intestin
epitheli
cell
influenc
gut
flora
local
immun
respons
express
specif
tlr
recognit
specif
antigen
epitheli
cell
tlr
stimul
differ
intracellular
signal
pathway
lead
differ
tlymphocyt
immun
respons
postul
ongo
immun
stimul
elicit
microbi
flora
gut
program
host
predomin
express
differ
thelper
cell
respons
h
h
h
refer
crosstalk
indigen
intestin
flora
bodi
immun
system
h
respons
describ
delayedtyp
hypersensit
cellular
immun
character
predomin
releas
h
primarili
humor
immun
antibodi
product
especi
ige
associ
il
h
respons
relat
oral
toler
antiinflammatori
effect
associ
releas
theoret
ideal
system
abil
host
respond
variou
stimuli
balanc
protect
microbi
invas
without
excess
inflamm
damag
host
imbalanc
poorli
regul
respons
system
could
result
allerg
reaction
food
protein
h
excess
autoimmun
inflammatori
respons
selfantigen
h
excess
ongo
research
continu
explor
molecular
mechan
potenti
contribut
allergi
autoimmun
diseas
normal
immun
function
develop
within
fetu
infant
young
child
role
breast
milk
develop
system
mucos
immun
system
take
new
signific
consid
concept
mechan
especi
true
examin
role
breast
milk
ad
innat
adapt
immun
respons
level
mucosa
effect
breast
milk
respiratori
intestin
microbiota
purport
antiinflammatori
effect
breast
milk
propos
influenc
breast
milk
matur
develop
intestin
vorbach
capecchi
penning
postul
mammari
gland
evolv
protect
immun
gland
part
innat
immun
system
present
list
variou
protect
molecul
part
mucos
secret
human
milk
discuss
specif
nutrit
factor
human
milk
dual
function
nutrit
protect
highlight
dual
role
breast
nutrit
immun
organ
stimul
research
breast
role
innat
immun
compon
mucos
immun
system
investig
microbi
colon
intestin
tract
explod
much
investig
driven
new
molecular
techniqu
involv
analysi
ribosom
rna
sequenc
microb
might
identifi
tradit
cultur
techniqu
divers
microbiota
microb
colon
gi
tract
view
differ
perspect
base
technic
method
use
probiot
broadli
defin
microorgan
exist
within
host
afford
benefit
organ
host
prebiot
substanc
differ
mechan
increas
growth
surviv
probiot
bacteria
within
host
commonli
recogn
probiot
bacteria
lactobacillu
rhamnosu
gg
bifidobacteria
infanti
streptococcu
thermophilu
bacillu
subtili
saccharomyc
boulardii
bifidobacteria
bifidu
mani
organ
consid
probiot
commerci
avail
prebiot
predominantli
nondigest
oligosaccharid
ferment
within
colon
chang
ambient
ph
produc
smallchain
fatti
acid
breast
milk
signific
composit
oligosaccharid
function
prebiot
sourc
infant
facilit
growth
bifidobacteria
lactobacilli
ongo
research
explor
potenti
mutual
benefici
relationship
microb
host
particular
attent
nutrit
avail
nutrient
energi
sourc
synthesi
vitamin
influenc
microb
develop
gi
tract
includ
angiogenesi
mucos
barrier
repair
matur
mucos
immun
innat
system
adapt
system
bioavail
metabol
drug
chemic
gi
tract
specif
propos
mechan
probiot
bacteria
prebiot
substanc
contribut
infant
develop
immun
system
includ
competit
pathogen
bacteria
colon
strengthen
tight
junction
enhanc
mucos
barrier
produc
antimicrobi
bacteriocidin
stimul
mucu
product
stimul
peristalsi
influenc
secret
siga
stimul
crosstalk
interact
intestin
cell
colon
bacteria
affect
mucos
immun
develop
increas
product
certain
cytokin
interf
microbi
colon
infant
intestin
tract
begin
birth
organ
matern
flora
first
colon
numer
addit
factor
directli
influenc
composit
intestin
microbiota
earli
infanc
includ
gestat
age
ingest
breast
milk
formula
initi
solid
food
mode
deliveri
rout
deliveri
food
time
onset
feed
exposur
microb
contact
famili
anim
person
environ
antibiot
intercurr
chronic
ill
predomin
flora
breastf
infant
lactobacillu
bifidu
bifidobacterium
spp
constitut
cultur
organ
remain
minor
bacteria
includ
streptococcu
bacteroid
clostridium
micrococcu
enterococcu
e
coli
uncommon
organ
small
number
lactobacillu
bifidu
metabol
milk
saccharid
produc
larg
amount
acet
acid
lactic
acid
formic
succin
acid
creat
low
ph
stool
breastf
infant
l
bifidu
also
produc
shortchain
fatti
acid
cours
colon
larg
number
bifidobacteria
lower
ph
intestin
limit
growth
pathogen
e
coli
bacteroid
staphylococci
flora
bifid
bacteria
inhibitori
certain
pathogen
bacteria
substanti
clinic
evid
avail
demonstr
protect
intestin
infect
saureu
shigella
salmonella
vibrio
cholera
e
coli
rotaviru
campylobact
protozoa
two
facilitori
action
breast
milk
appar
first
encourag
growth
l
bifidu
thu
crowd
growth
bacteria
second
number
pathogen
also
kept
low
direct
action
lysozym
lactoferrin
number
pathogen
bacteria
kept
low
immun
antibodi
keep
growth
potenti
pathogen
bacteria
control
limit
invas
bacteria
gut
wall
bloodstream
intestin
flora
formulaf
infant
made
predominantli
gramneg
bacteria
especi
coliform
organ
bacteroid
includ
clostridium
enterobact
enterococcu
studi
demonstr
potenti
four
distinctli
differ
microhabitat
microflora
within
gi
lumen
within
mucu
layer
separ
within
crypt
mucu
directli
surfac
intestin
epithelium
signific
microhabitat
effect
specif
microorgan
yet
determin
wean
facult
anaerob
declin
number
oblig
anaerob
bacteroid
becom
predomin
organ
intestin
preterm
infant
colon
differ
type
number
bacteria
full
term
infant
environ
neonat
intens
care
unit
nicu
includ
incub
widespread
use
antibiot
parenter
nutrit
ill
influenc
microbi
colon
shortand
longterm
effect
differ
chang
gi
microbiota
concern
particularli
true
one
consid
contribut
factor
caus
sepsi
nec
chronic
lung
diseas
poor
neurolog
outcom
nicu
question
causal
role
intestin
microflora
develop
nec
prematur
verylowbirthweight
vlbw
infant
propos
gewolb
et
al
suggest
low
percentag
bifidobacterium
lactobacillu
stool
vlbw
infant
within
first
month
life
risk
factor
infect
studi
use
probiot
occurr
nec
demonstr
lower
incid
nec
infant
receiv
probiot
use
mother
breast
milk
prematur
infant
vlbw
infant
decreas
risk
infant
sepsi
nec
infectionrel
event
control
prospect
studi
highrisk
lowbirthweight
infant
india
use
donor
human
milk
significantli
fewer
infect
major
infect
found
group
receiv
human
milk
although
control
infant
experienc
diarrhea
pneumonia
septicemia
mening
properti
human
milk
appear
control
limit
infect
infant
hundr
articl
written
protect
effect
breastfeed
includ
recent
agenc
healthcar
research
qualiti
public
breastfeed
matern
infant
health
outcom
develop
countri
use
evidencebas
analys
report
document
decreas
risk
acut
otiti
media
gi
infect
lower
respiratori
tract
diseas
breastf
infant
develop
countri
breast
milk
iga
antitoxin
activ
enterotoxin
e
coli
v
cholera
may
signific
prevent
infantil
diarrhea
antibodi
antigen
common
serotyp
e
coli
found
high
titer
breast
milk
sampl
collect
healthi
mother
sweden
infant
consum
reason
amount
breast
milk
high
titer
e
coli
antibodi
antibodi
stool
protect
cholera
breastf
children
antibodi
breast
milk
studi
glass
et
al
prospect
studi
bangladesh
show
cholera
antibodi
level
vari
colostrum
milk
correl
among
colon
diseas
milk
antibodi
led
author
conclud
breast
milk
antibodi
cholera
protect
children
colon
v
cholera
protect
diseas
salmonella
infect
similarli
studi
franc
et
al
evalu
immunolog
mechan
host
colostrum
milk
specif
salmonella
vigor
respons
colostr
milk
cell
organ
nonspecif
opson
capac
aqueou
phase
colostrum
milk
demonstr
gothefor
et
al
show
e
coli
isol
stool
breastf
infant
differ
strain
found
formulaf
infant
two
respect
first
e
coli
strain
sensit
bactericid
effect
human
serum
second
often
spontan
agglutin
bacteria
site
prepuc
periurethr
area
less
sensit
breastf
infant
find
support
theori
breast
milk
favor
prolifer
mutant
strain
decreas
virul
mutat
bacteri
strain
anoth
way
breastfeed
may
protect
infect
suggest
milk
immun
dynam
process
mother
milk
found
contain
antibodi
virtual
infant
strain
intestin
bacteria
mother
expos
infant
microorgan
either
breast
gut
respond
immunolog
microorgan
thu
directli
provid
protect
immunolog
immatur
infant
orderli
review
data
presenc
antibodi
human
milk
produc
substanti
list
affect
organ
addit
e
coli
antibodi
bacteroid
fragili
clostridium
tetani
haemophilu
pertussi
diplococcu
pneumonia
corynebacterium
diphtheria
salmonella
shigella
chlamydia
trachomati
v
cholera
aureu
sever
strain
streptococcu
tabl
identifi
nogueraobenza
cleari
summar
contribut
siga
breast
milk
protect
infant
bacteri
enter
studi
oslo
hanson
outbreak
sever
diarrhea
caus
e
coli
strain
show
six
sever
ill
children
formula
fed
two
infant
breastf
e
coli
strain
stool
show
symptom
mother
detect
antibodi
strain
milk
would
suggest
factor
human
milk
protect
infant
seriou
ill
antibodi
milk
hanson
also
report
result
anoth
studi
colon
specif
strain
e
coli
mother
larg
number
lymphoid
cell
milk
antibodi
e
coli
mother
serum
show
respons
support
concept
antigentrigg
lymphoid
cell
peyer
patch
seek
lymphoidrich
tissu
produc
iga
mammari
gland
mother
immun
gut
time
milk
also
shown
e
coli
enter
cure
feed
human
milk
schlesing
covelli
studi
possibl
cellmedi
immun
breastf
infant
show
tuberculinposit
nurs
mother
reactiv
cell
colostrum
earli
milk
furthermor
infant
nurs
tuberculinposit
mother
tuberculinreact
peripher
blood
cell
week
cord
blood
activ
clinic
research
data
suggest
protect
effect
appar
induc
tuberculin
reactiv
infant
avail
protect
virus
subject
similar
studi
breast
milk
contain
antibodi
polioviru
coxsackieviru
echoviru
enteroviru
influenza
viru
reoviru
rsv
rotaviru
rhinoviru
confirm
human
milk
inhibit
growth
virus
tissu
cultur
nonspecif
substanc
human
milk
activ
arboviru
murin
leukemia
viru
accord
work
fieldsteel
high
degre
antivir
activ
japanes
b
enceph
viru
well
two
leukemia
virus
found
human
milk
factor
found
fat
fraction
destroy
extend
heat
distinguish
antibodi
may
believ
nonimmunoglobulin
macromolecul
antivir
activ
human
milk
caus
specif
fatti
acid
monoglycerid
tabl
import
recogn
factor
besid
immmunoglobulin
contain
breast
milk
play
role
protect
breastfeed
infant
viral
infect
specimen
human
colostrum
found
contain
neutral
activ
rsv
rsv
becom
major
threat
infanc
common
reason
hospit
infanc
develop
countri
high
mortal
rate
epidem
occur
special
care
nurseri
statist
signific
data
collect
downham
et
al
show
compar
uninfect
control
subject
breastf
breastf
babi
among
infant
hospit
rsv
infect
fishaut
et
al
studi
immun
respons
rsv
prospect
nurs
mother
sever
month
antivir
igm
igg
rare
found
colostrum
milk
rsvspecif
iga
howev
identifi
specimen
two
mother
diseas
specif
igg
igm
iga
antibodi
serum
nasopharyng
secret
iga
found
milk
confirm
iga
antibodi
specif
respiratori
tract
pathogen
present
product
lactat
rsv
appear
replic
respiratori
tract
author
suggest
viralspecif
antibodi
activ
mammari
gland
may
deriv
bronchioleassoci
lymphoid
tissu
human
milk
bile
saltstimul
lipas
found
major
factor
inactiv
protozoan
tabl
mechan
lipas
act
known
although
may
gener
fatti
acid
monoglycerid
inactiv
envelop
bacteria
virus
protozoa
nonimmunoglobulin
nonlipas
heatstabl
factor
identifi
human
milk
inactiv
giardia
lamblia
human
milk
protect
mani
intestin
respiratori
pathogen
minim
evid
inflamm
goldman
et
al
hypothes
human
milk
poor
initi
mediat
inflamm
rich
antiinflammatori
agent
sever
major
biochem
pathway
inflamm
includ
coagul
system
fibrinolyt
system
complement
poorli
repres
human
milk
box
outlin
antiinflammatori
properti
variou
constitu
pauciti
certain
proinflammatori
mediat
breast
milk
interact
factor
milk
one
anoth
host
defens
entir
predict
examin
factor
separ
decreas
respons
human
milk
leukocyt
chemoattract
peptid
demonstr
thorp
et
al
failur
respons
human
milk
leukocyt
caus
alter
matern
peripher
blood
leukocyt
suggest
inhibitor
milk
human
milk
leukocyt
may
modifi
mammari
gland
protect
noninflammatori
mechan
low
number
basophil
mast
dell
eosinophil
cytotox
tcell
present
breast
milk
mani
studi
document
decreas
function
milk
polymorphonuclear
leukocyt
macrophag
colostrum
matur
milk
antioxid
properti
human
colostrum
demonstr
buescher
mcilheran
use
aqueou
human
colostrum
human
pmn
colostrum
significantli
interf
pmn
oxygen
metabol
enzymat
activ
import
mediat
acut
inflamm
antioxid
breast
milk
also
contribut
overal
antiinflammatori
effect
breast
milk
demonstr
antioxid
contain
breast
milk
includ
ascorbatelik
compound
uric
acid
lhistidin
scaveng
oxygen
radic
blood
level
higher
breastf
unsuppl
formulaf
infant
catalas
glutathion
peroxidas
lactoferrin
function
antioxid
antioxid
activ
demonstr
colostrum
lower
level
matur
human
milk
addit
specif
cytokin
exhibit
antiinflammatori
effect
also
identifi
human
colostrum
milk
cytokin
antagonist
solubl
receptor
also
found
colostrum
milk
palkowetz
et
al
report
decreas
action
human
colostrum
milk
caus
diminish
influx
polymorphonuclear
cell
local
site
inflamm
two
differ
vivo
model
inflamm
rat
inflammatori
respons
protect
host
time
produc
symptom
clinic
ill
breast
milk
contain
larg
varieti
antimicrobi
factor
exert
protect
effect
without
caus
signific
inflamm
eg
siga
oligosaccharid
lactoferrin
nucleotid
mani
cell
factor
breast
milk
particip
complex
interact
protect
infant
limit
potenti
damag
effect
uncontrol
inflammatori
respons
studi
dynam
interplay
mani
factor
breast
milk
develop
infant
mucos
barrier
immun
system
need
fulli
understand
protect
immun
respons
antiinflammatori
benefit
human
milk
see
chapter
human
milk
prophylaxi
allergi
discuss
allerg
protect
properti
human
milk
difficult
identifi
specif
protect
factor
prove
protect
allergi
equal
difficult
discuss
propos
mechan
protect
exact
mechan
oral
toler
remain
theoret
rel
import
contribut
factor
hypersensit
must
still
adequ
defin
import
variabl
concern
toler
sensit
genet
background
host
natur
dose
antigen
frequenc
exposur
time
age
first
subsequ
exposur
immunolog
statu
host
rout
exposur
neonat
period
small
intestin
increas
permeabl
macromolecul
infant
serum
secretori
antibodi
dietari
protein
children
adult
product
iga
intestin
tract
delay
week
month
age
iga
colostrum
breast
milk
prevent
absorpt
foreign
macromolecul
infant
immun
system
immatur
mucin
oligosaccharid
factor
within
breast
milk
may
affect
antigen
present
protein
breast
milk
speci
specif
therefor
nonallerg
human
infant
antibodi
respons
demonstr
occur
human
milk
infant
also
shown
macromolecul
breast
milk
absorb
indirect
evid
infer
demonstr
infant
respons
cow
milk
protein
within
day
take
cow
milk
infant
begin
develop
antibodi
sinc
advent
prepar
formula
protein
denatur
heat
dri
incid
cow
milk
allergi
consid
reliabl
mean
diagnos
cow
milk
allergi
challeng
isol
cow
milk
protein
although
circul
antibodi
coproantibodi
identifi
reliabl
techniqu
clinician
involv
patient
care
allerg
syndrom
associ
cow
milk
allergi
includ
gastroenteropathi
atop
dermat
allerg
rhiniti
chronic
pulmonari
diseas
asthma
eosinophilia
failur
thrive
sudden
infant
death
syndrom
cot
death
case
attribut
anaphylaxi
cow
milk
gi
symptom
receiv
greatest
attent
includ
spittingup
colic
diarrhea
blood
stool
frank
vomit
weight
loss
malabsorpt
coliti
failur
thrive
cow
milk
associ
gi
protein
blood
loss
diagnosi
best
made
elimin
cow
milk
diet
appropri
challeng
test
cutan
test
littl
help
cow
milk
allergi
describ
breastf
infant
exclus
breastfeed
alon
suffici
protect
infant
high
risk
becom
sensit
cow
milk
protein
incid
cow
milk
allergi
exclus
breastf
infant
estim
compar
overal
incid
rang
populationbas
studi
murray
show
associ
nasal
secret
eosinophilia
infant
freeli
fed
cow
milk
solid
food
compar
eosinophilia
strictli
breastf
infant
infant
receiv
cow
milk
high
eosinophil
secret
breastf
infant
eosinophil
present
nasal
secret
surprisingli
mani
differ
antigen
specif
recogn
colostrum
milk
one
speci
fed
inject
anoth
speci
cow
milk
high
list
food
allergen
particularli
children
sensit
cow
milk
respons
least
pediatr
allerg
condit
accord
gerrard
evid
indic
iga
antibodi
play
import
role
confin
food
antigen
gut
food
antigen
given
bottlef
infant
make
iga
depriv
human
milk
plasma
cell
may
expect
readili
absorb
glaser
first
made
associ
drop
breastfeed
rise
allergi
pioneer
theori
prophylact
manag
allergi
allergi
infanc
associ
famili
histori
atop
diseas
elev
cord
blood
ige
level
introduct
foreign
protein
infant
diet
even
mother
diet
breastfeed
dyad
lead
allerg
symptom
infant
exclus
breastfeed
protect
highrisk
children
allerg
symptom
unless
mother
also
adher
close
restrict
diet
exclud
common
allergen
larg
bodi
literatur
examin
whether
breastfeed
protect
atop
diseas
kramer
defin
standard
methodolog
studi
allergi
breastfeed
standard
clarifi
definit
breastfeed
measur
outcom
diagnost
criteria
specif
allerg
syndrom
defin
children
high
risk
atop
diseas
address
method
decreas
bia
control
confound
variabl
sever
recent
larg
metaanalys
perform
assess
protect
effect
breastfeed
allerg
rhiniti
atop
dermat
asthma
exclus
breastfeed
first
month
life
protect
allerg
rhiniti
summari
odd
ratio
confid
interv
without
famili
histori
atopi
exclus
breastfeed
least
month
associ
lower
rate
atop
dermat
children
famili
histori
atopi
exclus
breastfeed
first
month
life
protect
asthma
childhood
odd
ratio
confid
interv
chapter
discuss
prophylact
manag
potenti
allerg
infant
major
element
human
milk
relat
infant
immun
system
directact
antimicrobi
factor
antiinflammatori
factor
immunomodul
bioactiv
compound
epidemiolog
studi
produc
compel
inform
suggest
breastfeed
month
longer
provid
immunolog
protect
childhoodonset
diseas
viirtanen
et
al
report
prospect
longterm
studi
among
children
finland
show
significantli
lower
incid
type
diabet
atrisk
children
breastf
month
longer
epidemiolog
studi
demonstr
decreas
incid
type
insulindepend
diabet
mellitu
breastf
children
clinic
observ
support
laboratori
studi
diet
control
diabet
mice
isol
bovin
albumin
peptid
possibl
trigger
type
insulindepend
diabet
mellitu
make
studi
imper
base
limit
data
recent
agenc
healthcar
research
qualiti
report
cautious
conclud
breastfeed
least
month
reduc
risk
type
diabet
compar
breastfeed
less
month
type
diabet
report
conclud
breastfeed
infanc
produc
decreas
risk
compar
breastfeed
review
nation
perinat
collabor
studi
davi
et
al
show
protect
effect
develop
childhood
cancer
breastf
month
longer
children
follow
year
effect
greater
acut
leukemia
lymphoma
role
infant
feed
practic
show
similar
effect
breastfeed
protect
postpon
decreas
occurr
inflammatori
bowel
diseas
childhood
greco
et
al
report
decreas
risk
celiac
diseas
breastf
infant
ahrq
report
conclud
associ
exist
breastfeed
least
month
decreas
risk
develop
acut
lymphocyt
leukemia
acut
myelogen
leukemia
matern
renal
allograft
better
surviv
rate
individu
breastf
infanc
compar
breastf
mechan
appar
longterm
immunolog
benefit
remain
unclear
although
theori
abound
given
potenti
confound
factor
bia
larg
longterm
studi
confirm
propos
benefit
addit
care
control
trial
requir
increas
amount
accumul
epidemiolog
literatur
util
improv
methodolog
statist
demonstr
protect
benefit
human
milk
infant
larg
number
bioactiv
factor
identifi
measur
breast
milk
period
lactat
addit
research
need
clarifi
interact
mechan
action
mani
bioactiv
factor
human
milk
correl
immunomodulatori
action
specif
protect
benefit
infant
